Dr. W.W. Mellema

Top-cited publications

69 times cited (±9/year) Source: Scopus

Lung cancer (Amsterdam, Netherlands), Volume 84, Issue 1, 23 4 2014, Pages 86-91 EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases? Hendriks LE, Smit EF, Vosse BA, Mellema WW, Heideman DA, Bootsma GP, Westenend M, Pitz C, de Vries GJ, Houben R, Grünberg K, Bendek M, Speel EJ, Dingemans AM. Abstract


43 times cited (±6/year) Source: Scopus

International journal of cancer, Volume 136, Issue 6, 8 2 2014, Pages 1434-1444 Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation. Groenendijk FH, Mellema WW, van der Burg E, Schut E, Hauptmann M, Horlings HM, Willems SM, van den Heuvel MM, Jonkers J, Smit EF, Bernards R. Abstract


42 times cited (±5/year) Source: EuropePMC

Clinical cancer research : an official journal of the American Association for Cancer Research, Volume 19, Issue 3, 6 1 2012, Pages 743-751 A phase II study of sorafenib in patients with platinum-pretreated, advanced (Stage IIIb or IV) non-small cell lung cancer with a KRAS mutation. Dingemans AM, Mellema WW, Groen HJ, van Wijk A, Burgers SA, Kunst PW, Thunnissen E, Heideman DA, Smit EF. Abstract


Most recent publications

15 Sep 2015

Lung cancer (Amsterdam, Netherlands), Volume 90, Issue 2, 15 3 2015, Pages 249-254 Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer. Mellema WW, Masen-Poos L, Smit EF, Hendriks LE, Aerts JG, Termeer A, Goosens MJ, Smit HJ, van den Heuvel MM, van der Wekken AJ, Herder GJ, Krouwels FH, Stigt JA, van den Borne BE, Haitjema TJ, Staal-Van den Brekel AJ, van Heemst RC, Pouw E, Dingemans AM. Abstract


01 Feb 2015

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, Volume 10, Issue 2, 1 1 2015, Pages e9 Difference in outcome between types of KRAS mutation may point toward difference in tumor biology. Mellema WW, Dingemans AM, Jonker M, Smit EF. Abstract


29 Nov 2014

Lung cancer (Amsterdam, Netherlands), Volume 87, Issue 2, 29 5 2014, Pages 201-203 Tumor flare after start of RAF inhibition in KRAS mutated NSCLC: a case report. Mellema WW, Burgers SA, Smit EF. Abstract